Fidia Pharma USA Inc. Partners With AEONSurgical To Expand Its US Sales Presence

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARSIPPANY, N.J. & SAN ANTONIO--(BUSINESS WIRE)--Fidia Pharma USA Inc., a wholly-owned subsidiary of Fidia Farmaceutici SpA, an international specialty pharmaceutical company and recognized leader in hyaluronic acid-based products, announced today the completion of a sales and marketing agreement with AEONSurgical, a leading group of independent sales representatives to physician and hospital customers across the US.

Effective September 15, 2014, AEONSurgical’s team will sell Hyalgan® alongside Fidia’s direct sales force. Oscar N. Obledo, CEO & Founder of AEONSurgical, said, “Our partnership with Fidia Pharma USA demonstrates our continued commitment to working with Joint Healthcare manufacturers who develop innovative technologies that assist in positive outcomes for Osteoarthritis patients, while also providing an economical solution for hospitals and physicians."

Help employers find you! Check out all the jobs and post your resume.

Back to news